STOCK TITAN

ZimVie to Present at the 41st Annual J.P. Morgan Healthcare Conference

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Rhea-AI Summary

ZimVie Inc. (Nasdaq: ZIMV), a leader in life sciences within the dental and spine markets, will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco. CEO Vafa Jamali is scheduled to speak on January 11, 2023, at 3:00 p.m. PT. The presentation will be accessible via a live and archived webcast. Founded in March 2022 as a spin-off from Zimmer Biomet, ZimVie provides a wide range of dental and spine solutions across over 70 countries, focusing on product innovation and clinical evidence.

Loading...
Loading translation...
Argus Session date unavailable
+1.92% session move Open Argus
Details

News Market Reaction – ZIMV

The recorded move for ZIMV in the trading session of this news was +1.92%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

WESTMINSTER, Colo., Dec. 28, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that management will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, California.

Vafa Jamali, President and Chief Executive Officer, is scheduled to present on Wednesday, January 11, 2023, at 3:00 p.m. Pacific Time. Interested parties may access a live and archived version of the webcast of the presentation at: https://investor.zimvie.com/events-presentations/event-calendar.

About ZimVie
ZimVie is a global life sciences leader in the dental and spine markets that develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to treat a wide range of spine pathologies and support dental tooth replacement and restoration procedures. The company was founded in March 2022 as an independent, publicly traded spin-off of the Dental and Spine business units of Zimmer Biomet to breathe new life, dedicated energy, and strategic focus to its portfolio of trusted brands and products. From its headquarters in Westminster, Colorado, and additional facilities around the globe, the company serves customers in over 70 countries worldwide with a robust offering of dental and spine solutions including differentiated product platforms supported by extensive clinical evidence.
For more information about ZimVie, please visit us at www.ZimVie.com. Follow @ZimVie on Twitter, Facebook, LinkedIn, or Instagram.

Media Contact Information:

ZimVie
Laura Driscoll • Laura.Driscoll@ZimVie.com
(774) 284-1606

Investor Contact Information:

Gilmartin Group LLC
Marissa Bych • Marissa@gilmartinir.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will ZimVie present at the J.P. Morgan Healthcare Conference?

ZimVie will present on January 11, 2023, at 3:00 p.m. Pacific Time.

Who is the CEO of ZimVie presenting at the conference?

Vafa Jamali is the President and CEO of ZimVie who will present at the conference.

How can I access the ZimVie presentation at the conference?

The presentation can be accessed live and in an archived format at ZimVie's investor relations website.

What markets does ZimVie operate in?

ZimVie operates in the dental and spine markets, offering a range of products for various medical needs.

When was ZimVie founded?

ZimVie was founded in March 2022 as a spin-off from Zimmer Biomet.

In how many countries does ZimVie serve customers?

ZimVie serves customers in over 70 countries worldwide.

Keep reading